Price target
285.320.00 0.00%
The 11 analysts offering 1 year price forecasts for UTH have a max estimate of — and a min estimate of —.
Analyst rating
Based on 14 analysts giving stock ratings to UTH in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
UTH EPS for the last quarter is 5.72 EUR despite the estimation of 5.29 EUR. In the next quarter EPS is expected to reach 5.95 EUR. Track more of UNITED THERAPEUTICS CORP financials and stay on top of what is up with the company.
In the next quarter UNITED THERAPEUTICS CORP revenue is expected to reach 634.88 M EUR. Check out UNITED THERAPEUTICS CORP revenue and earnings and make informed decisions.
According to analysts, UTH price target is 285.32 EUR with a max estimate of 374.53 EUR and a min estimate of 224.72 EUR. Check if this forecast comes true in a year, meanwhile watch UNITED THERAPEUTICS CORP stock price chart and keep track of the current situation with UTH news and stock market news.
We've gathered opinions of 14 analysts rating UTH stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.